TrianglePUBLICATIONS · 34762296
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2022 Mar 1
- First author
- Katzenstein HM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Katzenstein HM
- type
- Author
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo MD
- type
- Author
- name
- Piao J
- type
- Author
- name
- Towbin AJ
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- Tiao GM
- type
- Author
- name
- Dunn SP
- type
- Author
- name
- Langham MR
- type
- Author
- name
- McGahren ED
- type
- Author
- name
- Finegold MJ
- type
- Author
- name
- Ranganathan S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Katzenstein HM
- type
- Author
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo MD
- type
- Author
- name
- Piao J
- type
- Author
- name
- Towbin AJ
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- Tiao GM
- type
- Author
- name
- Dunn SP
- type
- Author
- name
- Langham MR
- type
- Author
- name
- McGahren ED
- type
- Author
- name
- Finegold MJ
- type
- Author
- name
- Ranganathan S
- type
- Author
- bibliography ids
- nci-bib-9d7a8283b69c287e88a8a582
- book metadata
- content sha256
- 98af97943c97c82b3900460418f3501976cf2f934737465bb7e3c7e866343c7a
- document type
- citation
- dois
- 10.1002/cncr.34014
- electronic publication date
- display
- 2021 Nov 11
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34762296
- immutable id
- pubmed:34762296@98af97943c97c82b3900460418f3501976cf2f934737465bb7e3c7e866343c7a
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 5
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 1057-1065
- volume
- 128
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34762296
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- d333dc995f3c687fdd5e6c818bf18cc88698723c1e3706e857fec76801a62740
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Mar 1
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase III
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
Preserved source evidence · Not medical advice